Archer Investment Corporation’s Novo Nordisk NVO Stock Holding History

Archer Investment Corporation’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10K	Buy	209 +5	+2%	+$215	﹤0.01%	789
2026 Q1	$7.5K	Hold	204	–	–	﹤0.01%	852
2025 Q4	$10.4K	Hold	204	–	–	﹤0.01%	718
2025 Q3	$11.3K	Buy	204 +101	+98%	+$5.91K	﹤0.01%	712
2025 Q2	$7.11K	Buy	103 +1	+1%	+$68	﹤0.01%	772
2025 Q1	$7.06K	Hold	102	–	–	﹤0.01%	755
2024 Q4	$8.75K	Sell	102 -19	-16%	-$2.06K	﹤0.01%	718
2024 Q3	$14.4K	Buy	121 +20	+20%	+$2.67K	﹤0.01%	623
2024 Q2	$14.5K	Hold	101	–	–	﹤0.01%	603
2024 Q1	$13K	Sell	101 -17	-14%	-$2.02K	﹤0.01%	608
2023 Q4	$12.2K	Buy	118 +17	+17%	+$1.68K	﹤0.01%	614
2023 Q3	$9.17K	Buy	101 +1	+1%	+$88	﹤0.01%	642
2023 Q2	$8.13K	Hold	100	–	–	﹤0.01%	659
2023 Q1	$7.96K	Buy	+100	New	+$7.09K	﹤0.01%	599

Other funds holding NVO

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SRIM

Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return

Archer Investment Corporation's NVO Position: Q2 2026 in Review

Archer Investment Corporation increased its Novo Nordisk (NVO) stake by 2.5% in Q2 2026, buying an estimated $215 and bringing the position to 209 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #789.

Archer Investment Corporation first reported a position in NVO in Q1 2023 and has held it in 14 quarters since. The position peaked at $14.5K in Q2 2024. 1,052 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Archer Investment Corporation held 209 shares of Novo Nordisk worth $10K as of Q2 2026.
Archer Investment Corporation bought 5 Novo Nordisk shares in Q2 2026, an estimated $215.
Novo Nordisk made up ﹤0.01% of Archer Investment Corporation's portfolio in Q2 2026, its #789 holding.
Archer Investment Corporation first reported a position in Novo Nordisk in Q1 2023 and has held it in 14 quarters since.
Archer Investment Corporation's Novo Nordisk position peaked at $14.5K in Q2 2024.
1,052 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Archer Investment Corporation's 13F filing for Q2 2026, filed 3 Aug 2026.